查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1717129

男性荷尔蒙补充疗法市场（按治疗方法、应用和最终用户划分）—2025-2030 年全球预测

Testosterone Replacement Therapy Market by Treatment Method, Application, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

男性荷尔蒙补充疗法市场预计到 2024 年将达到 8.5048 亿美元，2025 年将达到 8.9836 亿美元，到 2030 年将达到 11.9035 亿美元，复合年增长率为 5.76%。

主要市场统计数据
基准年2024年 8.5048亿美元
预计2025年 8.9836亿美元
预测年份 2030 11.9035亿美元
复合年增长率（%） 5.76%

男性荷尔蒙补充疗法(TRT) 作为解决与老龄化相关的荷尔蒙失衡和相关健康问题的重要治疗选择，已获得广泛关注。近年来，由于人们对睪固酮在整体健康中的作用有了更深入的了解、对睪固酮缺乏症的诊断越来越多、以及对个人化医疗解决方案的兴趣日益浓厚，对 TRT 的需求猛增。这份综合报告深入探讨了 TRT 市场的新兴趋势、转型变化和多方面细分。

我们的分析对尖端治疗方法和市场驱动因素进行了深入的分析，说明了技术进步与不断变化的患者需求之间的关联。透过研究主要应用和不同的治疗方式，它强调了医疗保健行业如何适应提供更有效和客製化的治疗性介入。决策者和专家都将欣赏这些提供行业策略视角的详细见解。该报告将复杂的市场动态简化为可操作的讯息，以帮助相关人员清楚了解当前的机会和未来的挑战。这项研究注重清晰度和深度，为快速变化的治疗环境中的明智决策奠定了基础。

变革性变化重新定义睪固酮替代疗法市场

近年来，男性荷尔蒙补充疗法市场经历了重大变革时期，掀起了一波创新和策略重组的浪潮。这些变化的基础是医疗技术的快速进步、患者群体的变化以及不断重新定义行业标准的监管变化。

治疗方案从更具侵入性的手术介入发展到微创手术，有助于再形成患者体验和治疗结果。技术进步为更精确的给药方案和增强的给药机制铺平了道路，不仅提高了患者的依从性，而且改善了临床结果。随着实证医学占据中心地位，医疗保健提供者越来越多地采用针对每位患者独特的荷尔蒙状况的个人化治疗计划。此外，创新的临床试验和改进的诊断工具正在推动应用策略的演变，使治疗更加安全、有效。

这些转变将为研究、临床合作和技术投资开闢新的途径，从而推动扩大市场机会。透过利用这些变化，行业领导者有很大机会占领快速成长的市场占有率，同时满足未满足的患者需求。 TRT 领域正在经历一场动态转型，其特点是致力于准确性、效率和卓越的患者治疗结果。

突显市场机会的关键细分洞察

对男性荷尔蒙补充疗法市场的详细研究提供了一个先进的细分框架，有助于解读市场趋势和新兴机会。我们根据治疗方式、应用和最终用户对市场进行了详细的研究。基于治疗方法的分析剖析了植入和颗粒等新型输送系统的使用，以及频谱肌肉注射和皮下注射的注射疗法、鼻腔用药、口服疗法、颊部和/或颊部、通过经皮技术区分的贴剂以及不断发展的局部凝胶。

从应用的角度检验市场，人们重点关注骨骼密度和骨质疏鬆症管理的治疗，以及针对性腺功能低下的干预措施。后者又分为原发性性腺功能低下和继发性性腺功能低下，进一步强调增加性慾和改善情绪和认知功能。最终用户细分透过考虑治疗环境（从门诊手术中心到专科诊所到老牌医院）进一步细分市场动态。

这种详细的细分不仅揭示了市场的复杂性，而且还提供了有关消费行为、未满足的临床需求和潜在创新领域的关键见解。细分洞察为有针对性的投资和策略倡议提供了蓝图，旨在最大限度地提高市场渗透率并推动以患者为中心的成长。

目录

第一章 引言

第二章调查方法

第三章执行摘要

第四章 市场概述

第五章 市场洞察

  • 市场动态
    • 驱动程式
      • 提高对睪固酮缺乏症状的认识，提升男性荷尔蒙补充疗法的诊断能力
      • 提高对荷尔蒙补充疗法的认识
    • 限制因素
      • 与睪固酮治疗相关的副作用和安全问题
    • 机会
      • 越来越多的男性荷尔蒙补充疗法产品核准并不断创新
      • 利用数位健康和​​远端医疗平台提高男性荷尔蒙补充疗法的可近性
    • 任务
      • 男性荷尔蒙补充疗法监管核准更严格
  • 市场区隔分析
    • 治疗方法：具有长期临床疗效和成本效益的注射剂
    • 应用：男性荷尔蒙补充疗法治疗性腺功能低下的流行情况
    • 最终使用者：男性荷尔蒙补充疗法在临床上的普及
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社会
    • 技术的
    • 合法的
    • 环境

第六章男性荷尔蒙补充疗法市场（依治疗方法）

  • 植入/颗粒
  • 注射
    • 肌肉注射
    • 皮下
  • 鼻内用药
  • 口服药物
  • 修补
    • 脸颊/颧骨
    • 经皮
  • 外用凝胶

第七章男性荷尔蒙补充疗法市场（依应用）

  • 骨骼密度和骨质疏鬆症治疗
  • 性腺功能低下
    • 原发性性腺功能低下
    • 继发性性腺功能续发性
  • 提高性慾
  • 改善情绪和认知能力

第八章男性荷尔蒙补充疗法市场（按最终用户）

  • 门诊手术中心
  • 诊所
  • 医院

9.美洲男性荷尔蒙补充疗法市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

10. 亚太地区男性荷尔蒙补充疗法市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

11. 欧洲、中东和非洲男性荷尔蒙补充疗法市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2024年市场占有率分析
  • 2024年FPNV定位矩阵
  • 竞争情境分析
  • 战略分析与建议

公司名单

  • Acerus Pharmaceuticals Corporation
  • Actiza Pharmaceutical Pvt. Ltd.
  • ADVANZ PHARMA Corp.
  • Alembic Limited
  • ASKA Pharmaceutical Co., Ltd.
  • Aurobindo Pharma Limited
  • Bausch Health Companies Inc.
  • Bayer AG
  • Besins Healthcare Monaco SAM
  • Bora Pharmaceuticals Co., Ltd.
  • Cipla Limited
  • Dr. Reddy's Laboratories Limited
  • Eli Lilly and Company
  • Endo International PLC
  • EVER Pharma Jena GmbH
  • Grunenthal
  • Halozyme, Inc.
  • Hikma Pharmaceuticals PLC
  • LIPOCINE Inc.
  • Lupin Limited
  • Marius Pharmaceuticals, Inc.
  • Perrigo Company PLC
  • Pfizer Inc.
  • REGENX Health
  • Simple Pharma
  • TesoRx Pharma, LLC
  • Teva Pharmaceutical Industries Ltd.
  • Tolmar, Inc.
  • Xiromed LLC
  • Zydus Lifesciences Limited
Product Code: MRR-957C47F93749

The Testosterone Replacement Therapy Market was valued at USD 850.48 million in 2024 and is projected to grow to USD 898.36 million in 2025, with a CAGR of 5.76%, reaching USD 1,190.35 million by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 850.48 million
Estimated Year [2025] USD 898.36 million
Forecast Year [2030] USD 1,190.35 million
CAGR (%) 5.76%

Testosterone Replacement Therapy (TRT) has garnered significant attention as a pivotal treatment option in addressing age-related hormonal imbalances and associated health challenges. Over the past few years, the demand for TRT has surged, driven by a better understanding of testosterone's role in overall health, the rise in diagnoses of testosterone deficiency, and an increasing inclination towards personalized healthcare solutions. This comprehensive report delves deep into emerging trends, transformational shifts, and the multifaceted segmentation of the TRT market.

Our analysis offers a robust exploration of cutting-edge treatment modalities and market drivers, illustrating the interplay between technological advances and evolving patient needs. By examining key applications and a diverse range of treatment methods, we highlight how the healthcare industry is adapting to offer more effective and customized therapeutic interventions. Decision-makers and experts alike will appreciate the detailed insights that provide a strategic bird's-eye view of the industry. The report further simplifies complex market dynamics into actionable intelligence, ensuring that stakeholders gain a clear understanding of current opportunities and the challenges that lie ahead. With an emphasis on clarity and depth, this study lays the groundwork for informed decision-making in a rapidly changing therapeutic landscape.

Transformative Shifts Redefining the Testosterone Replacement Therapy Market

Recent years have seen significant transformative shifts across the Testosterone Replacement Therapy market, ushering in waves of innovation and strategic realignment. These shifts are underpinned by the rapid advancements in medical technology, evolving patient demographics, and regulatory changes that continue to redefine industry standards.

The evolution of treatment options, from more invasive surgical interventions to minimally invasive procedures, has contributed to reshaping patient experiences and therapeutic outcomes. Technological advancements have paved the way for more precise dosing protocols and enhanced delivery mechanisms, which not only improve patient adherence but also bolster clinical outcomes. As evidence-based medicine takes center stage, providers are increasingly integrating personalized treatment plans that cater to the unique hormonal profiles of individual patients. Furthermore, innovative clinical trials and improved diagnostic tools are driving the evolution of application strategies, ensuring that treatments are both safer and more effective.

These transformative changes facilitate expanded market opportunities by opening new avenues for research, clinical collaboration, and technological investment. By leveraging these shifts, industry leaders have a prime opportunity to capture burgeoning market share while also addressing unmet patient needs. The landscape of TRT is in a state of dynamic transition, marked by a commitment to accuracy, efficiency, and superior patient outcomes.

Key Segmentation Insights Illuminating Market Opportunities

A granular look into the Testosterone Replacement Therapy market reveals a sophisticated segmentation framework that is instrumental in deciphering market trends and emerging opportunities. The market is meticulously studied based on treatment methods, applications, and end users. An analysis based on treatment method dissects the usage of implants and pellets, a spectrum of injectable therapies which is further divided into intramuscular and subcutaneous techniques, as well as novel delivery systems such as intranasal medications, oral therapies, patches differentiated by cheek or buccal and transdermal technologies, and the ever-evolving topical gels.

When examining the market through the lens of application, the focus extends across treatments for bone density and osteoporosis management along with interventions targeting hypogonadism. The latter classification is thoughtfully split into primary and secondary hypogonadism, while additional applications focus on boosting libido and enhancing mood and cognitive functions. The end user segmentation further refines the market dynamics by considering the setting in which therapies are administered, ranging from ambulatory surgical centers to specialized clinics and established hospitals.

This detailed segmentation not only unravels the market's complexity but also provides crucial insights into consumer behavior, unmet clinical demands, and potential areas for innovation. The segmentation insights offer a roadmap for targeted investments and strategic initiatives designed to maximize market penetration and drive patient-centric growth.

Based on Treatment Method, market is studied across Implants/Pellets, Injectable, Intranasal Medications, Oral Medications, Patches, and Topical Gel. The Injectable is further studied across Intramuscular and Subcutaneous. The Patches is further studied across Cheek/Buccal and Transdermal.

Based on Application, market is studied across Bone Density & Osteoporosis Treatment, Hypogonadism, Libido Improvement, and Mood & Cognitive Improvements. The Hypogonadism is further studied across Primary Hypogonadism and Secondary Hypogonadism.

Based on End User, market is studied across Ambulatory Surgical Centers, Clinics, and Hospitals.

Key Regional Insights Defining Global Market Dynamics

Regional dynamics play an indispensable role in shaping the Testosterone Replacement Therapy market, with distinct patterns emerging across global territories. Analysis reveals that variations in healthcare infrastructure, economic resources, regulatory frameworks, and cultural nuances drive the adoption and evolution of TRT therapies in different regions.

In the Americas, healthcare systems are robust and innovation-friendly, resulting in the early adoption of advanced treatment modalities. This region's focus on technology-driven healthcare solutions has spurred significant growth, with patient-centric models becoming the norm. Across Europe, the Middle East, and Africa, stringent regulatory environments coupled with a commitment to clinical excellence foster a market that places a premium on safety and efficacy. Here, the blend of traditional clinical practices with modern technological breakthroughs is evident. In contrast, the Asia-Pacific region is witnessing a rapid evolution, propelled by increasing awareness, expanded healthcare infrastructure, and a burgeoning middle class that drives demand for premium healthcare services.

These diverse regional insights help in understanding how local contexts influence treatment accessibility and innovation. The analysis underscores that while each region presents unique challenges and opportunities, the collective drive towards enhanced patient care continues to unify the global market, shaping a promising future for the industry.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Key Companies Insights Shaping the Competitive Market Landscape

The competitive landscape of the Testosterone Replacement Therapy market is robust, characterized by a blend of well-established and innovative companies that are actively redefining market paradigms. Leading firms such as Acerus Pharmaceuticals Corporation, Actiza Pharmaceutical Pvt. Ltd., and ADVANZ PHARMA Corp. are at the forefront of driving research and development, while other notable players include Alembic Limited and ASKA Pharmaceutical Co., Ltd. Their combined efforts have catalyzed a wave of new treatment modalities and regulatory advancements.

Moreover, prominent industry participants like Aurobindo Pharma Limited, Bausch Health Companies Inc., and Bayer AG are investing significantly in R&D to bolster their product portfolios. Companies such as Besins Healthcare Monaco S.A.M. and Bora Pharmaceuticals Co., Ltd. have demonstrated commitment to advancing patient-centric solutions, frequently collaborating on clinical trials and innovative drug delivery systems. Further, the innovative capabilities of firms like Cipla Limited, Dr. Reddy's Laboratories Limited, and Eli Lilly and Company contribute to the evolution of the therapeutic landscape. Market leaders such as Endo International PLC, EVER Pharma Jena GmbH, Grunenthal, and Halozyme, Inc. are also making significant strides, alongside industry influencers including Hikma Pharmaceuticals PLC, LIPOCINE Inc., and Lupin Limited. The market is further enriched by competitive insights from Marius Pharmaceuticals, Inc., Perrigo Company PLC, Pfizer Inc., REGENX Health, Simple Pharma, TesoRx Pharma, LLC, Teva Pharmaceutical Industries Ltd., Tolmar, Inc., Xiromed LLC, and Zydus Lifesciences Limited.

This diversified company insight underscores a market that is intensely competitive yet ripe with collaborative possibilities and innovative breakthroughs.

The report delves into recent significant developments in the Testosterone Replacement Therapy Market, highlighting leading vendors and their innovative profiles. These include Acerus Pharmaceuticals Corporation, Actiza Pharmaceutical Pvt. Ltd., ADVANZ PHARMA Corp., Alembic Limited, ASKA Pharmaceutical Co., Ltd., Aurobindo Pharma Limited, Bausch Health Companies Inc., Bayer AG, Besins Healthcare Monaco S.A.M., Bora Pharmaceuticals Co., Ltd., Cipla Limited, Dr. Reddy's Laboratories Limited, Eli Lilly and Company, Endo International PLC, EVER Pharma Jena GmbH, Grunenthal, Halozyme, Inc., Hikma Pharmaceuticals PLC, LIPOCINE Inc., Lupin Limited, Marius Pharmaceuticals, Inc., Perrigo Company PLC, Pfizer Inc., REGENX Health, Simple Pharma, TesoRx Pharma, LLC, Teva Pharmaceutical Industries Ltd., Tolmar, Inc., Xiromed LLC, and Zydus Lifesciences Limited. Actionable Recommendations Empowering Industry Leaders

For industry leaders navigating the Testosterone Replacement Therapy landscape, the path forward is paved with opportunities and challenges that require strategic foresight and agile execution. Decision-makers are encouraged to invest in advanced research and development initiatives, specifically seeking to innovate in treatment methodologies that offer improved precision and patient outcomes. Leveraging technological advancements to enhance drug delivery systems may not only bridge existing gaps but also set new benchmarks for efficacy.

Expanding geographical footprints and diversifying product portfolios based on local market dynamics is imperative. Leaders should prioritize forming strategic alliances, particularly in regions demonstrating high growth potential, to both share insights and mitigate risks. An emphasis on robust clinical research to validate emerging therapies, accompanied by proactive regulatory engagements, can significantly shorten market entry timelines and streamline approval processes. Furthermore, harnessing real-world data and integrating it into decision-making frameworks will significantly enhance the ability to predict trends and tailor interventions to nuanced patient needs.

It is crucial for stakeholders to continuously monitor global market dynamics, remain responsive to evolving consumer demands, and commit to an innovation-driven approach. By implementing these actionable recommendations, industry leaders can fortify their market positions and secure sustainable growth in a competitive global landscape.

Conclusion: Charting a Strategic Course for Future Growth

In conclusion, the Testosterone Replacement Therapy market is experiencing a period of dynamic transformation driven by a confluence of technological innovations, refined segmentation strategies, and evolving regional healthcare dynamics. This comprehensive report has illuminated how transformative shifts in treatment approaches and application areas are contributing to a more nuanced understanding of patient needs and market opportunities.

The intricate segmentation based on treatment method, application, and end user has offered vital insights into the diverse facets that shape market behavior. Regional insights have further enhanced our understanding by mapping out the distinct market drivers across the Americas, Europe, Middle East and Africa, and Asia-Pacific regions. The competitive contours defined by leading companies underscore an industry that not only values innovation and clinical excellence but also thrives on strategic collaboration and global outreach.

As the market continues to evolve, stakeholders must remain agile, informed, and strategically focused in order to capitalize on emerging trends and circumvent potential challenges. With robust recommendations and strategic insights outlined in this report, investors and industry leaders are well-equipped to steer their efforts towards a more prosperous future in the realm of Testosterone Replacement Therapy.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising awareness of testosterone deficiency symptoms and improved diagnostic capabilities for testosterone replacement therapy
      • 5.1.1.2. Increasing initiatives and programs to spread awareness of testosterone replacement therapy
    • 5.1.2. Restraints
      • 5.1.2.1. Side effects and safety concerns linked with testosterone treatment
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing approvals and innovative testosterone replacement therapy products
      • 5.1.3.2. Leveraging digital health and telemedicine platforms to improve accessibility of testosterone replacement therapy
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulatory approvals for testosterone replacement therapy
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Treatment Method: Usage of injectable formulations due to their long-established clinical efficacy and cost-effectiveness
    • 5.2.2. Application: Prevalence of testosterone replacement therapy for hypogonadism
    • 5.2.3. End User: Widespread adoption of testosterone replacement therapy in clinics
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Testosterone Replacement Therapy Market, by Treatment Method

  • 6.1. Introduction
  • 6.2. Implants/Pellets
  • 6.3. Injectable
    • 6.3.1. Intramuscular
    • 6.3.2. Subcutaneous
  • 6.4. Intranasal Medications
  • 6.5. Oral Medications
  • 6.6. Patches
    • 6.6.1. Cheek/Buccal
    • 6.6.2. Transdermal
  • 6.7. Topical Gel

7. Testosterone Replacement Therapy Market, by Application

  • 7.1. Introduction
  • 7.2. Bone Density & Osteoporosis Treatment
  • 7.3. Hypogonadism
    • 7.3.1. Primary Hypogonadism
    • 7.3.2. Secondary Hypogonadism
  • 7.4. Libido Improvement
  • 7.5. Mood & Cognitive Improvements

8. Testosterone Replacement Therapy Market, by End User

  • 8.1. Introduction
  • 8.2. Ambulatory Surgical Centers
  • 8.3. Clinics
  • 8.4. Hospitals

9. Americas Testosterone Replacement Therapy Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Testosterone Replacement Therapy Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Testosterone Replacement Therapy Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2024
  • 12.2. FPNV Positioning Matrix, 2024
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Marius Pharmaceuticals partners with Thrive to expand access to FDA-approved oral testosterone therapy
    • 12.3.2. Azmiro's FDA-approved prefilled syringe innovation transforms testosterone replacement therapy in US
    • 12.3.3. Lipocine's strategic licensing and distribution deal with SPC Korea expands growth in testosterone replacement therapy initiatives
    • 12.3.4. Tolmar's strategic telemedicine partnership with UpScriptHealth enhances direct patient access to JATENZO for testosterone replacement therapy
    • 12.3.5. LifeMD launches TestoRx on its Rex MD platform to expand comprehensive men's health
    • 12.3.6. WellSync and Marius Pharmaceuticals unite to deliver KYZATREX oral testosterone therapy
    • 12.3.7. iMD Companies, Inc. acquisition of Riize, LLC
    • 12.3.8. The Vitamin Shoppe partners with Marius Pharmaceuticals to integrate FDA-approved KYZATREX into whole health telehealth services for holistic testosterone replacement therapy(TRT)
    • 12.3.9. MangoRx launches PRIME as an FDA-approved oral testosterone replacement therapy
    • 12.3.10. Pharmac funds testosterone gel to offer an accessible and flexible hormone replacement therapy
  • 12.4. Strategy Analysis & Recommendation
    • 12.4.1. Tolmar, Inc.
    • 12.4.2. Grunenthal
    • 12.4.3. Pfizer Inc.
    • 12.4.4. Marius Pharmaceuticals Inc.

Companies Mentioned

  • 1. Acerus Pharmaceuticals Corporation
  • 2. Actiza Pharmaceutical Pvt. Ltd.
  • 3. ADVANZ PHARMA Corp.
  • 4. Alembic Limited
  • 5. ASKA Pharmaceutical Co., Ltd.
  • 6. Aurobindo Pharma Limited
  • 7. Bausch Health Companies Inc.
  • 8. Bayer AG
  • 9. Besins Healthcare Monaco S.A.M.
  • 10. Bora Pharmaceuticals Co., Ltd.
  • 11. Cipla Limited
  • 12. Dr. Reddy's Laboratories Limited
  • 13. Eli Lilly and Company
  • 14. Endo International PLC
  • 15. EVER Pharma Jena GmbH
  • 16. Grunenthal
  • 17. Halozyme, Inc.
  • 18. Hikma Pharmaceuticals PLC
  • 19. LIPOCINE Inc.
  • 20. Lupin Limited
  • 21. Marius Pharmaceuticals, Inc.
  • 22. Perrigo Company PLC
  • 23. Pfizer Inc.
  • 24. REGENX Health
  • 25. Simple Pharma
  • 26. TesoRx Pharma, LLC
  • 27. Teva Pharmaceutical Industries Ltd.
  • 28. Tolmar, Inc.
  • 29. Xiromed LLC
  • 30. Zydus Lifesciences Limited

LIST OF FIGURES

  • FIGURE 1. TESTOSTERONE REPLACEMENT THERAPY MARKET MULTI-CURRENCY
  • FIGURE 2. TESTOSTERONE REPLACEMENT THERAPY MARKET MULTI-LANGUAGE
  • FIGURE 3. TESTOSTERONE REPLACEMENT THERAPY MARKET RESEARCH PROCESS
  • FIGURE 4. TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, 2024 VS 2030
  • FIGURE 5. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, 2018-2030 (USD THOUSAND)
  • FIGURE 6. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD THOUSAND)
  • FIGURE 7. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD THOUSAND)
  • FIGURE 8. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY TREATMENT METHOD, 2024 VS 2030 (%)
  • FIGURE 9. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY TREATMENT METHOD, 2024 VS 2025 VS 2030 (USD THOUSAND)
  • FIGURE 10. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 11. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD THOUSAND)
  • FIGURE 12. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2024 VS 2030 (%)
  • FIGURE 13. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD THOUSAND)
  • FIGURE 14. AMERICAS TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 15. AMERICAS TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD THOUSAND)
  • FIGURE 16. UNITED STATES TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 17. UNITED STATES TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD THOUSAND)
  • FIGURE 18. ASIA-PACIFIC TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD THOUSAND)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD THOUSAND)
  • FIGURE 22. TESTOSTERONE REPLACEMENT THERAPY MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 23. TESTOSTERONE REPLACEMENT THERAPY MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. TESTOSTERONE REPLACEMENT THERAPY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, 2018-2030 (USD THOUSAND)
  • TABLE 4. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 5. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
  • TABLE 6. TESTOSTERONE REPLACEMENT THERAPY MARKET DYNAMICS
  • TABLE 7. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 8. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY IMPLANTS/PELLETS, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 9. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 10. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 11. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 12. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD THOUSAND)
  • TABLE 13. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INTRANASAL MEDICATIONS, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 14. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY ORAL MEDICATIONS, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 15. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PATCHES, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 16. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY CHEEK/BUCCAL, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 17. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY TRANSDERMAL, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 18. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PATCHES, 2018-2030 (USD THOUSAND)
  • TABLE 19. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY TOPICAL GEL, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 20. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 21. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY BONE DENSITY & OSTEOPOROSIS TREATMENT, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 22. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY HYPOGONADISM, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 23. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PRIMARY HYPOGONADISM, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 24. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY SECONDARY HYPOGONADISM, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 25. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY HYPOGONADISM, 2018-2030 (USD THOUSAND)
  • TABLE 26. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY LIBIDO IMPROVEMENT, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 27. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY MOOD & COGNITIVE IMPROVEMENTS, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 28. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD THOUSAND)
  • TABLE 29. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 30. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 31. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 32. AMERICAS TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 33. AMERICAS TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD THOUSAND)
  • TABLE 34. AMERICAS TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PATCHES, 2018-2030 (USD THOUSAND)
  • TABLE 35. AMERICAS TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 36. AMERICAS TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY HYPOGONADISM, 2018-2030 (USD THOUSAND)
  • TABLE 37. AMERICAS TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD THOUSAND)
  • TABLE 38. AMERICAS TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
  • TABLE 39. ARGENTINA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 40. ARGENTINA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD THOUSAND)
  • TABLE 41. ARGENTINA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PATCHES, 2018-2030 (USD THOUSAND)
  • TABLE 42. ARGENTINA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 43. ARGENTINA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY HYPOGONADISM, 2018-2030 (USD THOUSAND)
  • TABLE 44. ARGENTINA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD THOUSAND)
  • TABLE 45. BRAZIL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 46. BRAZIL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD THOUSAND)
  • TABLE 47. BRAZIL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PATCHES, 2018-2030 (USD THOUSAND)
  • TABLE 48. BRAZIL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 49. BRAZIL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY HYPOGONADISM, 2018-2030 (USD THOUSAND)
  • TABLE 50. BRAZIL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD THOUSAND)
  • TABLE 51. CANADA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 52. CANADA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD THOUSAND)
  • TABLE 53. CANADA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PATCHES, 2018-2030 (USD THOUSAND)
  • TABLE 54. CANADA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 55. CANADA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY HYPOGONADISM, 2018-2030 (USD THOUSAND)
  • TABLE 56. CANADA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD THOUSAND)
  • TABLE 57. MEXICO TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 58. MEXICO TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD THOUSAND)
  • TABLE 59. MEXICO TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PATCHES, 2018-2030 (USD THOUSAND)
  • TABLE 60. MEXICO TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 61. MEXICO TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY HYPOGONADISM, 2018-2030 (USD THOUSAND)
  • TABLE 62. MEXICO TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD THOUSAND)
  • TABLE 63. UNITED STATES TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 64. UNITED STATES TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD THOUSAND)
  • TABLE 65. UNITED STATES TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PATCHES, 2018-2030 (USD THOUSAND)
  • TABLE 66. UNITED STATES TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 67. UNITED STATES TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY HYPOGONADISM, 2018-2030 (USD THOUSAND)
  • TABLE 68. UNITED STATES TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD THOUSAND)
  • TABLE 69. UNITED STATES TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY STATE, 2018-2030 (USD THOUSAND)
  • TABLE 70. ASIA-PACIFIC TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 71. ASIA-PACIFIC TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD THOUSAND)
  • TABLE 72. ASIA-PACIFIC TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PATCHES, 2018-2030 (USD THOUSAND)
  • TABLE 73. ASIA-PACIFIC TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 74. ASIA-PACIFIC TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY HYPOGONADISM, 2018-2030 (USD THOUSAND)
  • TABLE 75. ASIA-PACIFIC TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD THOUSAND)
  • TABLE 76. ASIA-PACIFIC TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
  • TABLE 77. AUSTRALIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 78. AUSTRALIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD THOUSAND)
  • TABLE 79. AUSTRALIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PATCHES, 2018-2030 (USD THOUSAND)
  • TABLE 80. AUSTRALIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 81. AUSTRALIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY HYPOGONADISM, 2018-2030 (USD THOUSAND)
  • TABLE 82. AUSTRALIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD THOUSAND)
  • TABLE 83. CHINA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 84. CHINA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD THOUSAND)
  • TABLE 85. CHINA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PATCHES, 2018-2030 (USD THOUSAND)
  • TABLE 86. CHINA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 87. CHINA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY HYPOGONADISM, 2018-2030 (USD THOUSAND)
  • TABLE 88. CHINA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD THOUSAND)
  • TABLE 89. INDIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 90. INDIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD THOUSAND)
  • TABLE 91. INDIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PATCHES, 2018-2030 (USD THOUSAND)
  • TABLE 92. INDIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 93. INDIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY HYPOGONADISM, 2018-2030 (USD THOUSAND)
  • TABLE 94. INDIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD THOUSAND)
  • TABLE 95. INDONESIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 96. INDONESIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD THOUSAND)
  • TABLE 97. INDONESIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PATCHES, 2018-2030 (USD THOUSAND)
  • TABLE 98. INDONESIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 99. INDONESIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY HYPOGONADISM, 2018-2030 (USD THOUSAND)
  • TABLE 100. INDONESIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD THOUSAND)
  • TABLE 101. JAPAN TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 102. JAPAN TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD THOUSAND)
  • TABLE 103. JAPAN TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PATCHES, 2018-2030 (USD THOUSAND)
  • TABLE 104. JAPAN TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 105. JAPAN TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY HYPOGONADISM, 2018-2030 (USD THOUSAND)
  • TABLE 106. JAPAN TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD THOUSAND)
  • TABLE 107. MALAYSIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 108. MALAYSIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD THOUSAND)
  • TABLE 109. MALAYSIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PATCHES, 2018-2030 (USD THOUSAND)
  • TABLE 110. MALAYSIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 111. MALAYSIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY HYPOGONADISM, 2018-2030 (USD THOUSAND)
  • TABLE 112. MALAYSIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD THOUSAND)
  • TABLE 113. PHILIPPINES TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 114. PHILIPPINES TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD THOUSAND)
  • TABLE 115. PHILIPPINES TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PATCHES, 2018-2030 (USD THOUSAND)
  • TABLE 116. PHILIPPINES TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 117. PHILIPPINES TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY HYPOGONADISM, 2018-2030 (USD THOUSAND)
  • TABLE 118. PHILIPPINES TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD THOUSAND)
  • TABLE 119. SINGAPORE TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 120. SINGAPORE TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD THOUSAND)
  • TABLE 121. SINGAPORE TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PATCHES, 2018-2030 (USD THOUSAND)
  • TABLE 122. SINGAPORE TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 123. SINGAPORE TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY HYPOGONADISM, 2018-2030 (USD THOUSAND)
  • TABLE 124. SINGAPORE TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD THOUSAND)
  • TABLE 125. SOUTH KOREA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 126. SOUTH KOREA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD THOUSAND)
  • TABLE 127. SOUTH KOREA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PATCHES, 2018-2030 (USD THOUSAND)
  • TABLE 128. SOUTH KOREA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 129. SOUTH KOREA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY HYPOGONADISM, 2018-2030 (USD THOUSAND)
  • TABLE 130. SOUTH KOREA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD THOUSAND)
  • TABLE 131. TAIWAN TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 132. TAIWAN TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD THOUSAND)
  • TABLE 133. TAIWAN TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PATCHES, 2018-2030 (USD THOUSAND)
  • TABLE 134. TAIWAN TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 135. TAIWAN TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY HYPOGONADISM, 2018-2030 (USD THOUSAND)
  • TABLE 136. TAIWAN TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD THOUSAND)
  • TABLE 137. THAILAND TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 138. THAILAND TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD THOUSAND)
  • TABLE 139. THAILAND TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PATCHES, 2018-2030 (USD THOUSAND)
  • TABLE 140. THAILAND TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 141. THAILAND TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY HYPOGONADISM, 2018-2030 (USD THOUSAND)
  • TABLE 142. THAILAND TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD THOUSAND)
  • TABLE 143. VIETNAM TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 144. VIETNAM TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD THOUSAND)
  • TABLE 145. VIETNAM TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PATCHES, 2018-2030 (USD THOUSAND)
  • TABLE 146. VIETNAM TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 147. VIETNAM TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY HYPOGONADISM, 2018-2030 (USD THOUSAND)
  • TABLE 148. VIETNAM TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD THOUSAND)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD THOUSAND)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PATCHES, 2018-2030 (USD THOUSAND)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY HYPOGONADISM, 2018-2030 (USD THOUSAND)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD THOUSAND)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
  • TABLE 156. DENMARK TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 157. DENMARK TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD THOUSAND)
  • TABLE 158. DENMARK TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PATCHES, 2018-2030 (USD THOUSAND)
  • TABLE 159. DENMARK TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 160. DENMARK TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY HYPOGONADISM, 2018-2030 (USD THOUSAND)
  • TABLE 161. DENMARK TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD THOUSAND)
  • TABLE 162. EGYPT TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 163. EGYPT TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD THOUSAND)
  • TABLE 164. EGYPT TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PATCHES, 2018-2030 (USD THOUSAND)
  • TABLE 165. EGYPT TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 166. EGYPT TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY HYPOGONADISM, 2018-2030 (USD THOUSAND)
  • TABLE 167. EGYPT TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD THOUSAND)
  • TABLE 168. FINLAND TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 169. FINLAND TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD THOUSAND)
  • TABLE 170. FINLAND TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PATCHES, 2018-2030 (USD THOUSAND)
  • TABLE 171. FINLAND TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 172. FINLAND TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY HYPOGONADISM, 2018-2030 (USD THOUSAND)
  • TABLE 173. FINLAND TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD THOUSAND)
  • TABLE 174. FRANCE TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 175. FRANCE TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD THOUSAND)
  • TABLE 176. FRANCE TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PATCHES, 2018-2030 (USD THOUSAND)
  • TABLE 177. FRANCE TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 178. FRANCE TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY HYPOGONADISM, 2018-2030 (USD THOUSAND)
  • TABLE 179. FRANCE TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD THOUSAND)
  • TABLE 180. GERMANY TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 181. GERMANY TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD THOUSAND)
  • TABLE 182. GERMANY TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PATCHES, 2018-2030 (USD THOUSAND)
  • TABLE 183. GERMANY TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 184. GERMANY TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY HYPOGONADISM, 2018-2030 (USD THOUSAND)
  • TABLE 185. GERMANY TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD THOUSAND)
  • TABLE 186. ISRAEL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 187. ISRAEL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD THOUSAND)
  • TABLE 188. ISRAEL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PATCHES, 2018-2030 (USD THOUSAND)
  • TABLE 189. ISRAEL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 190. ISRAEL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY HYPOGONADISM, 2018-2030 (USD THOUSAND)
  • TABLE 191. ISRAEL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD THOUSAND)
  • TABLE 192. ITALY TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 193. ITALY TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD THOUSAND)
  • TABLE 194. ITALY TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PATCHES, 2018-2030 (USD THOUSAND)
  • TABLE 195. ITALY TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 196. ITALY TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY HYPOGONADISM, 2018-2030 (USD THOUSAND)
  • TABLE 197. ITALY TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD THOUSAND)
  • TABLE 198. NETHERLANDS TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 199. NETHERLANDS TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD THOUSAND)
  • TABLE 200. NETHERLANDS TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PATCHES, 2018-2030 (USD THOUSAND)
  • TABLE 201. NETHERLANDS TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 202. NETHERLANDS TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY HYPOGONADISM, 2018-2030 (USD THOUSAND)
  • TABLE 203. NETHERLANDS TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD THOUSAND)
  • TABLE 204. NIGERIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 205. NIGERIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD THOUSAND)
  • TABLE 206. NIGERIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PATCHES, 2018-2030 (USD THOUSAND)
  • TABLE 207. NIGERIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 208. NIGERIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY HYPOGONADISM, 2018-2030 (USD THOUSAND)
  • TABLE 209. NIGERIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD THOUSAND)
  • TABLE 210. NORWAY TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 211. NORWAY TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD THOUSAND)
  • TABLE 212. NORWAY TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PATCHES, 2018-2030 (USD THOUSAND)
  • TABLE 213. NORWAY TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 214. NORWAY TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY HYPOGONADISM, 2018-2030 (USD THOUSAND)
  • TABLE 215. NORWAY TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD THOUSAND)
  • TABLE 216. POLAND TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 217. POLAND TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD THOUSAND)
  • TABLE 218. POLAND TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PATCHES, 2018-2030 (USD THOUSAND)
  • TABLE 219. POLAND TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 220. POLAND TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY HYPOGONADISM, 2018-2030 (USD THOUSAND)
  • TABLE 221. POLAND TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD THOUSAND)
  • TABLE 222. QATAR TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 223. QATAR TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD THOUSAND)
  • TABLE 224. QATAR TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PATCHES, 2018-2030 (USD THOUSAND)
  • TABLE 225. QATAR TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 226. QATAR TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY HYPOGONADISM, 2018-2030 (USD THOUSAND)
  • TABLE 227. QATAR TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD THOUSAND)
  • TABLE 228. RUSSIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 229. RUSSIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD THOUSAND)
  • TABLE 230. RUSSIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PATCHES, 2018-2030 (USD THOUSAND)
  • TABLE 231. RUSSIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 232. RUSSIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY HYPOGONADISM, 2018-2030 (USD THOUSAND)
  • TABLE 233. RUSSIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD THOUSAND)
  • TABLE 234. SAUDI ARABIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 235. SAUDI ARABIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD THOUSAND)
  • TABLE 236. SAUDI ARABIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PATCHES, 2018-2030 (USD THOUSAND)
  • TABLE 237. SAUDI ARABIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 238. SAUDI ARABIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY HYPOGONADISM, 2018-2030 (USD THOUSAND)
  • TABLE 239. SAUDI ARABIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD THOUSAND)
  • TABLE 240. SOUTH AFRICA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 241. SOUTH AFRICA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD THOUSAND)
  • TABLE 242. SOUTH AFRICA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PATCHES, 2018-2030 (USD THOUSAND)
  • TABLE 243. SOUTH AFRICA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 244. SOUTH AFRICA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY HYPOGONADISM, 2018-2030 (USD THOUSAND)
  • TABLE 245. SOUTH AFRICA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD THOUSAND)
  • TABLE 246. SPAIN TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 247. SPAIN TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD THOUSAND)
  • TABLE 248. SPAIN TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PATCHES, 2018-2030 (USD THOUSAND)
  • TABLE 249. SPAIN TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 250. SPAIN TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY HYPOGONADISM, 2018-2030 (USD THOUSAND)
  • TABLE 251. SPAIN TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD THOUSAND)
  • TABLE 252. SWEDEN TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 253. SWEDEN TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD THOUSAND)
  • TABLE 254. SWEDEN TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PATCHES, 2018-2030 (USD THOUSAND)
  • TABLE 255. SWEDEN TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 256. SWEDEN TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY HYPOGONADISM, 2018-2030 (USD THOUSAND)
  • TABLE 257. SWEDEN TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD THOUSAND)
  • TABLE 258. SWITZERLAND TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 259. SWITZERLAND TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD THOUSAND)
  • TABLE 260. SWITZERLAND TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PATCHES, 2018-2030 (USD THOUSAND)
  • TABLE 261. SWITZERLAND TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 262. SWITZERLAND TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY HYPOGONADISM, 2018-2030 (USD THOUSAND)
  • TABLE 263. SWITZERLAND TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD THOUSAND)
  • TABLE 264. TURKEY TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 265. TURKEY TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD THOUSAND)
  • TABLE 266. TURKEY TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PATCHES, 2018-2030 (USD THOUSAND)
  • TABLE 267. TURKEY TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 268. TURKEY TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY HYPOGONADISM, 2018-2030 (USD THOUSAND)
  • TABLE 269. TURKEY TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD THOUSAND)
  • TABLE 270. UNITED ARAB EMIRATES TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 271. UNITED ARAB EMIRATES TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD THOUSAND)
  • TABLE 272. UNITED ARAB EMIRATES TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PATCHES, 2018-2030 (USD THOUSAND)
  • TABLE 273. UNITED ARAB EMIRATES TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 274. UNITED ARAB EMIRATES TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY HYPOGONADISM, 2018-2030 (USD THOUSAND)
  • TABLE 275. UNITED ARAB EMIRATES TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD THOUSAND)
  • TABLE 276. UNITED KINGDOM TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 277. UNITED KINGDOM TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD THOUSAND)
  • TABLE 278. UNITED KINGDOM TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PATCHES, 2018-2030 (USD THOUSAND)
  • TABLE 279. UNITED KINGDOM TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 280. UNITED KINGDOM TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY HYPOGONADISM, 2018-2030 (USD THOUSAND)
  • TABLE 281. UNITED KINGDOM TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD THOUSAND)
  • TABLE 282. TESTOSTERONE REPLACEMENT THERAPY MARKET SHARE, BY KEY PLAYER, 2024
  • TABLE 283. TESTOSTERONE REPLACEMENT THERAPY MARKET, FPNV POSITIONING MATRIX, 2024